跳至主要内容
临床试验/NCT05193422
NCT05193422Unknown不适用

Effects of Protective Face Masks on Cardiopulmonary Parameters at Rest and During Exercise in Children

University of Patras0 个研究点目标入组 40 人开始时间: 2022年1月20日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
40
主要终点
Temperature

研究概览

简要总结

This study will examine the possible effects of protective surgical masks on the cardiorespiratory function of children aged 8-14 years at rest and during exercise.

The study will consist of two phases:

  • Phase I: No face mask.
  1. Measurement of peak nasal inspiratory flow
  2. CPET with an ergometric bike at 30% of their predicted maximum workload (Wmax) for 4 minutes, 50% of Wmax for 2 minutes and 70% of Wmax for 1 minute, with continuous oxygen saturation (SpΟ2), heart rate (HR), end-tidal CO2 (EtCO2) and respiratory rate (RR) monitoring.
  3. Spirometry and measurement of nPIF immediately after CPET.
  4. Discomfort assessment using a special scale
  • Phase II: Face mask. Following nPIF measurement, participants will be asked to wear a standard surgical face mask. A temperature and humidity sensor will also be placed inside the mask. Will follow:
  1. Resting phase, 6 minutes. SpO2, HR, EtCO2 and RR will be monitored.
  2. CPET at 30% of Wmax for 4 minutes, 50% Wmax for 2 minutes and 70% Wmax for 1 minute. SpO2, HR, EtCO2 and RR will be continuously monitored.
  3. Spirometry and measurement of nPIF immediately after CPET.
  4. Discomfort assessment.

Both phases will be performed on the same day with a recovery phase of 30 minutes between them. Participants will be randomized to begin with Phase I followed by Phase II or Phase II followed by Phase I.

At both phases, SpO2, HR, EtCO2 and RR (10 s average values) will be recorder at each 1 minute during CPET, and at minutes 0, 3 and 6 during the resting phase of Phase II. During Phase II, temperature and humidity will also be recorded at each 1 minute during CPET and at minutes 0, 3 and 6 during the resting phase.

The total duration of the protocol is estimated at 90 minutes per participant. The study sample will consist of 40 children stratified by age.

详细描述

PURPOSE

The purpose of this study is to investigate the possible effects of protective surgical masks on the cardiorespiratory function of children aged 8-14 years at rest and during exercise.

METHODS

A. Population

Children aged 8-14 years (minimum height 135 cm) will be invited to participate. They will be recruited from the outpatient clinics of the Pediatric Allergy and Pediatric Endocrinology Departments of the University Hospital of Patras, Greece. Children should not suffer from conditions that are likely to affect cardiopulmonary exercise testing (CPET) outcomes, such as respiratory (asthma and chronic lung disease), cardiac (congenital heart disease, heart failure), neurologic and musculoskeletal disorders.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Other
盲法
None

入排标准

年龄范围
8 Years 至 14 Years(Child)
性别
All
接受健康志愿者
是

入选标准

  • •Children should not suffer from conditions that are likely to affect CPET outcomes, such as respiratory (asthma and chronic lung disease), cardiac (congenital heart disease, heart failure), neurologic and musculoskeletal disorders.
  • •Height >135 cm
  • •Parental written informed consent

排除标准

  • •Points #1 or #2 not fulfilled
  • •Child not willing to participate (e.g. not willing to wear the sensors)

研究组 & 干预措施

Phase I: No mask

Active Comparator

Participants, without wearing a face mask, will undergo the following:

  1. Measurement of peak nasal inspiratory flow
  2. Cardiopulmonary exercise testing (CPET) with an ergometric bike at 30% of their predicted maximum workload (Wmax) for 4 minutes, 50% of Wmax for 2 minutes and 70% of Wmax for 1 minute, with continuous oxygen saturation (SpΟ2), heart rate (HR), end-tidal CO2 (EtCO2) and respiratory rate (RR) monitoring.
  3. Spirometry and measurement of nPIF immediately after CPET.
  4. Discomfort assessment using a special scale

干预措施: Spirometry - baseline (Diagnostic Test)

Phase I: No mask

Active Comparator

Participants, without wearing a face mask, will undergo the following:

  1. Measurement of peak nasal inspiratory flow
  2. Cardiopulmonary exercise testing (CPET) with an ergometric bike at 30% of their predicted maximum workload (Wmax) for 4 minutes, 50% of Wmax for 2 minutes and 70% of Wmax for 1 minute, with continuous oxygen saturation (SpΟ2), heart rate (HR), end-tidal CO2 (EtCO2) and respiratory rate (RR) monitoring.
  3. Spirometry and measurement of nPIF immediately after CPET.
  4. Discomfort assessment using a special scale

干预措施: Spirometry - post CPET (Diagnostic Test)

Phase I: No mask

Active Comparator

Participants, without wearing a face mask, will undergo the following:

  1. Measurement of peak nasal inspiratory flow
  2. Cardiopulmonary exercise testing (CPET) with an ergometric bike at 30% of their predicted maximum workload (Wmax) for 4 minutes, 50% of Wmax for 2 minutes and 70% of Wmax for 1 minute, with continuous oxygen saturation (SpΟ2), heart rate (HR), end-tidal CO2 (EtCO2) and respiratory rate (RR) monitoring.
  3. Spirometry and measurement of nPIF immediately after CPET.
  4. Discomfort assessment using a special scale

干预措施: Nasal peak inspiratory flow - baseline (Diagnostic Test)

Phase I: No mask

Active Comparator

Participants, without wearing a face mask, will undergo the following:

  1. Measurement of peak nasal inspiratory flow
  2. Cardiopulmonary exercise testing (CPET) with an ergometric bike at 30% of their predicted maximum workload (Wmax) for 4 minutes, 50% of Wmax for 2 minutes and 70% of Wmax for 1 minute, with continuous oxygen saturation (SpΟ2), heart rate (HR), end-tidal CO2 (EtCO2) and respiratory rate (RR) monitoring.
  3. Spirometry and measurement of nPIF immediately after CPET.
  4. Discomfort assessment using a special scale

干预措施: Oxygen saturation (Diagnostic Test)

Phase I: No mask

Active Comparator

Participants, without wearing a face mask, will undergo the following:

  1. Measurement of peak nasal inspiratory flow
  2. Cardiopulmonary exercise testing (CPET) with an ergometric bike at 30% of their predicted maximum workload (Wmax) for 4 minutes, 50% of Wmax for 2 minutes and 70% of Wmax for 1 minute, with continuous oxygen saturation (SpΟ2), heart rate (HR), end-tidal CO2 (EtCO2) and respiratory rate (RR) monitoring.
  3. Spirometry and measurement of nPIF immediately after CPET.
  4. Discomfort assessment using a special scale

干预措施: Nasal peak inspiratory flow - post CPET (Diagnostic Test)

Phase I: No mask

Active Comparator

Participants, without wearing a face mask, will undergo the following:

  1. Measurement of peak nasal inspiratory flow
  2. Cardiopulmonary exercise testing (CPET) with an ergometric bike at 30% of their predicted maximum workload (Wmax) for 4 minutes, 50% of Wmax for 2 minutes and 70% of Wmax for 1 minute, with continuous oxygen saturation (SpΟ2), heart rate (HR), end-tidal CO2 (EtCO2) and respiratory rate (RR) monitoring.
  3. Spirometry and measurement of nPIF immediately after CPET.
  4. Discomfort assessment using a special scale

干预措施: Heart Rate (Diagnostic Test)

Phase I: No mask

Active Comparator

Participants, without wearing a face mask, will undergo the following:

  1. Measurement of peak nasal inspiratory flow
  2. Cardiopulmonary exercise testing (CPET) with an ergometric bike at 30% of their predicted maximum workload (Wmax) for 4 minutes, 50% of Wmax for 2 minutes and 70% of Wmax for 1 minute, with continuous oxygen saturation (SpΟ2), heart rate (HR), end-tidal CO2 (EtCO2) and respiratory rate (RR) monitoring.
  3. Spirometry and measurement of nPIF immediately after CPET.
  4. Discomfort assessment using a special scale

干预措施: End-tidal CO2 (Diagnostic Test)

Phase I: No mask

Active Comparator

Participants, without wearing a face mask, will undergo the following:

  1. Measurement of peak nasal inspiratory flow
  2. Cardiopulmonary exercise testing (CPET) with an ergometric bike at 30% of their predicted maximum workload (Wmax) for 4 minutes, 50% of Wmax for 2 minutes and 70% of Wmax for 1 minute, with continuous oxygen saturation (SpΟ2), heart rate (HR), end-tidal CO2 (EtCO2) and respiratory rate (RR) monitoring.
  3. Spirometry and measurement of nPIF immediately after CPET.
  4. Discomfort assessment using a special scale

干预措施: Respiratory rate (Diagnostic Test)

Phase I: No mask

Active Comparator

Participants, without wearing a face mask, will undergo the following:

  1. Measurement of peak nasal inspiratory flow
  2. Cardiopulmonary exercise testing (CPET) with an ergometric bike at 30% of their predicted maximum workload (Wmax) for 4 minutes, 50% of Wmax for 2 minutes and 70% of Wmax for 1 minute, with continuous oxygen saturation (SpΟ2), heart rate (HR), end-tidal CO2 (EtCO2) and respiratory rate (RR) monitoring.
  3. Spirometry and measurement of nPIF immediately after CPET.
  4. Discomfort assessment using a special scale

干预措施: Cardiopulmonary exercise testing (Diagnostic Test)

Phase I: No mask

Active Comparator

Participants, without wearing a face mask, will undergo the following:

  1. Measurement of peak nasal inspiratory flow
  2. Cardiopulmonary exercise testing (CPET) with an ergometric bike at 30% of their predicted maximum workload (Wmax) for 4 minutes, 50% of Wmax for 2 minutes and 70% of Wmax for 1 minute, with continuous oxygen saturation (SpΟ2), heart rate (HR), end-tidal CO2 (EtCO2) and respiratory rate (RR) monitoring.
  3. Spirometry and measurement of nPIF immediately after CPET.
  4. Discomfort assessment using a special scale

干预措施: Discomfort level (Diagnostic Test)

Phase II: Face mask

Experimental

Following nPIF measurement, participants will be asked to wear a standard surgical face mask. A temperature and humidity sensor will also be placed inside the mask. Will follow:

  1. Resting phase, 6 minutes. SpO2, HR, EtCO2 and RR will be monitored.
  2. CPET at 30% of Wmax for 4 minutes, 50% Wmax for 2 minutes and 70% Wmax for 1 minute. SpO2, HR, EtCO2 and RR will be continuously monitored.
  3. Spirometry and measurement of nPIF immediately after CPET.
  4. Discomfort assessment.

干预措施: Spirometry - post CPET (Diagnostic Test)

Phase II: Face mask

Experimental

Following nPIF measurement, participants will be asked to wear a standard surgical face mask. A temperature and humidity sensor will also be placed inside the mask. Will follow:

  1. Resting phase, 6 minutes. SpO2, HR, EtCO2 and RR will be monitored.
  2. CPET at 30% of Wmax for 4 minutes, 50% Wmax for 2 minutes and 70% Wmax for 1 minute. SpO2, HR, EtCO2 and RR will be continuously monitored.
  3. Spirometry and measurement of nPIF immediately after CPET.
  4. Discomfort assessment.

干预措施: Nasal peak inspiratory flow - baseline (Diagnostic Test)

Phase II: Face mask

Experimental

Following nPIF measurement, participants will be asked to wear a standard surgical face mask. A temperature and humidity sensor will also be placed inside the mask. Will follow:

  1. Resting phase, 6 minutes. SpO2, HR, EtCO2 and RR will be monitored.
  2. CPET at 30% of Wmax for 4 minutes, 50% Wmax for 2 minutes and 70% Wmax for 1 minute. SpO2, HR, EtCO2 and RR will be continuously monitored.
  3. Spirometry and measurement of nPIF immediately after CPET.
  4. Discomfort assessment.

干预措施: Nasal peak inspiratory flow - post CPET (Diagnostic Test)

Phase II: Face mask

Experimental

Following nPIF measurement, participants will be asked to wear a standard surgical face mask. A temperature and humidity sensor will also be placed inside the mask. Will follow:

  1. Resting phase, 6 minutes. SpO2, HR, EtCO2 and RR will be monitored.
  2. CPET at 30% of Wmax for 4 minutes, 50% Wmax for 2 minutes and 70% Wmax for 1 minute. SpO2, HR, EtCO2 and RR will be continuously monitored.
  3. Spirometry and measurement of nPIF immediately after CPET.
  4. Discomfort assessment.

干预措施: Oxygen saturation (Diagnostic Test)

Phase II: Face mask

Experimental

Following nPIF measurement, participants will be asked to wear a standard surgical face mask. A temperature and humidity sensor will also be placed inside the mask. Will follow:

  1. Resting phase, 6 minutes. SpO2, HR, EtCO2 and RR will be monitored.
  2. CPET at 30% of Wmax for 4 minutes, 50% Wmax for 2 minutes and 70% Wmax for 1 minute. SpO2, HR, EtCO2 and RR will be continuously monitored.
  3. Spirometry and measurement of nPIF immediately after CPET.
  4. Discomfort assessment.

干预措施: Heart Rate (Diagnostic Test)

Phase II: Face mask

Experimental

Following nPIF measurement, participants will be asked to wear a standard surgical face mask. A temperature and humidity sensor will also be placed inside the mask. Will follow:

  1. Resting phase, 6 minutes. SpO2, HR, EtCO2 and RR will be monitored.
  2. CPET at 30% of Wmax for 4 minutes, 50% Wmax for 2 minutes and 70% Wmax for 1 minute. SpO2, HR, EtCO2 and RR will be continuously monitored.
  3. Spirometry and measurement of nPIF immediately after CPET.
  4. Discomfort assessment.

干预措施: End-tidal CO2 (Diagnostic Test)

Phase II: Face mask

Experimental

Following nPIF measurement, participants will be asked to wear a standard surgical face mask. A temperature and humidity sensor will also be placed inside the mask. Will follow:

  1. Resting phase, 6 minutes. SpO2, HR, EtCO2 and RR will be monitored.
  2. CPET at 30% of Wmax for 4 minutes, 50% Wmax for 2 minutes and 70% Wmax for 1 minute. SpO2, HR, EtCO2 and RR will be continuously monitored.
  3. Spirometry and measurement of nPIF immediately after CPET.
  4. Discomfort assessment.

干预措施: Respiratory rate (Diagnostic Test)

Phase II: Face mask

Experimental

Following nPIF measurement, participants will be asked to wear a standard surgical face mask. A temperature and humidity sensor will also be placed inside the mask. Will follow:

  1. Resting phase, 6 minutes. SpO2, HR, EtCO2 and RR will be monitored.
  2. CPET at 30% of Wmax for 4 minutes, 50% Wmax for 2 minutes and 70% Wmax for 1 minute. SpO2, HR, EtCO2 and RR will be continuously monitored.
  3. Spirometry and measurement of nPIF immediately after CPET.
  4. Discomfort assessment.

干预措施: Temperature (Diagnostic Test)

Phase II: Face mask

Experimental

Following nPIF measurement, participants will be asked to wear a standard surgical face mask. A temperature and humidity sensor will also be placed inside the mask. Will follow:

  1. Resting phase, 6 minutes. SpO2, HR, EtCO2 and RR will be monitored.
  2. CPET at 30% of Wmax for 4 minutes, 50% Wmax for 2 minutes and 70% Wmax for 1 minute. SpO2, HR, EtCO2 and RR will be continuously monitored.
  3. Spirometry and measurement of nPIF immediately after CPET.
  4. Discomfort assessment.

干预措施: Humidity (Diagnostic Test)

Phase II: Face mask

Experimental

Following nPIF measurement, participants will be asked to wear a standard surgical face mask. A temperature and humidity sensor will also be placed inside the mask. Will follow:

  1. Resting phase, 6 minutes. SpO2, HR, EtCO2 and RR will be monitored.
  2. CPET at 30% of Wmax for 4 minutes, 50% Wmax for 2 minutes and 70% Wmax for 1 minute. SpO2, HR, EtCO2 and RR will be continuously monitored.
  3. Spirometry and measurement of nPIF immediately after CPET.
  4. Discomfort assessment.

干预措施: Cardiopulmonary exercise testing (Diagnostic Test)

Phase II: Face mask

Experimental

Following nPIF measurement, participants will be asked to wear a standard surgical face mask. A temperature and humidity sensor will also be placed inside the mask. Will follow:

  1. Resting phase, 6 minutes. SpO2, HR, EtCO2 and RR will be monitored.
  2. CPET at 30% of Wmax for 4 minutes, 50% Wmax for 2 minutes and 70% Wmax for 1 minute. SpO2, HR, EtCO2 and RR will be continuously monitored.
  3. Spirometry and measurement of nPIF immediately after CPET.
  4. Discomfort assessment.

干预措施: Discomfort level (Diagnostic Test)

结局指标

主要结局

Temperature

时间窗: Minute 7

Air temperature (in degrees Celsius) within the face mask

Humidity

时间窗: Minute 7

Relative air humidity (%) within the face mask

EtCO2

时间窗: Minute 7

End-tidal CO2

Exercise-induced bronchoconstriction

时间窗: Minute 7

% change in FEV1 value before-after CPET

RR

时间窗: Minute 7

Respiratory rate

HR

时间窗: Minute 7

Heart rate

% change in nPIF

时间窗: Minute 7

% change in nPIF value before-after CPET

SpO2

时间窗: Minute 7

Oxygen saturation

Discomfort level

时间窗: Minute 7

Level of discomfort (specific questionnaire (5 items), scale 1 to 10) after CPET

HR

时间窗: Minute 4

Heart rate

HR

时间窗: Minute 5

Heart rate

HR

时间窗: Minute 6

Heart rate

EtCO2

时间窗: Minute 1

End-tidal CO2

EtCO2

时间窗: Minute 2

End-tidal CO2

EtCO2

时间窗: Minute 3

End-tidal CO2

EtCO2

时间窗: Minute 4

End-tidal CO2

SpO2

时间窗: Minute 1

Oxygen saturation

SpO2

时间窗: Minute 2

Oxygen saturation

HR

时间窗: Minute 1

Heart rate

HR

时间窗: Minute 2

Heart rate

HR

时间窗: Minute 3

Heart rate

SpO2

时间窗: Minute 3

Oxygen saturation

SpO2

时间窗: Minute 4

Oxygen saturation

SpO2

时间窗: Minute 5

Oxygen saturation

SpO2

时间窗: Minute 6

Oxygen saturation

EtCO2

时间窗: Minute 5

End-tidal CO2

EtCO2

时间窗: Minute 6

End-tidal CO2

RR

时间窗: Minute 1

Respiratory rate

RR

时间窗: Minute 2

Respiratory rate

RR

时间窗: Minute 3

Respiratory rate

RR

时间窗: Minute 4

Respiratory rate

RR

时间窗: Minute 5

Respiratory rate

RR

时间窗: Minute 6

Respiratory rate

Temperature

时间窗: Minute 1

Air temperature (in degrees Celsius) within the face mask

Temperature

时间窗: Minute 2

Air temperature (in degrees Celsius) within the face mask

Temperature

时间窗: Minute 3

Air temperature (in degrees Celsius) within the face mask

Temperature

时间窗: Minutε 4

Air temperature (in degrees Celsius) within the face mask

Temperature

时间窗: Minute 5

Air temperature (in degrees Celsius) within the face mask

Temperature

时间窗: Minute 6

Air temperature (in degrees Celsius) within the face mask

Humidity

时间窗: Minute 1

Relative air humidity (%) within the face mask

Humidity

时间窗: Minute 2

Relative air humidity (%) within the face mask

Humidity

时间窗: Minute 3

Relative air humidity (%) within the face mask

Humidity

时间窗: Minute 4

Relative air humidity (%) within the face mask

Humidity

时间窗: Minute 5

Relative air humidity (%) within the face mask

Humidity

时间窗: Minute 6

Relative air humidity (%) within the face mask

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Fouzas Sotirios

Assistant Professor of Pediatrics

University of Patras

相似试验